Sanna Lauslahti has been elected as a Board member of EFPIA.

EFPIA (European Federation of Pharmaceutical Industries and Associations) is the voice of the research-based pharmaceutical industry operating in Europe.

EFPIA has a direct membership of 36 national associations, 39 leading pharmaceutical companies and a growing number of small and medium-sized enterprises (SMEs). PIF is one of the member associations of EFPIA. 

EFPIA’s mission is to create a collaborative environment that enables its members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

PIF feels that it is important that Ms Lauslahti will be a EFPIA Board member for the next few years. Our objective is to act actively both in the international and in the national context.

EFPIA’s website.